{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:08:10Z","timestamp":1789610890499,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.schres.2016.05.010","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T10:30:01Z","timestamp":1464431401000},"page":"196-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia"],"prefix":"10.1016","volume":"176","author":[{"given":"Yin Yang","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei Hong","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long Tan","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Ping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.schres.2016.05.010_bb0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.yhbeh.2012.02.012","article-title":"The effects of the stress response on immune function in invertebrates: an evolutionary perspective on an ancient connection","volume":"62","author":"Adamo","year":"2012","journal-title":"Horm. Behav."},{"issue":"1","key":"10.1016\/j.schres.2016.05.010_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/pcn.12089","article-title":"Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: comparison with schizophrenia","volume":"68","author":"Altamura","year":"2014","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2016.05.010_bb0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2015.02.043","article-title":"Abnormal immune system development and function in schizophrenia helps reconcile diverse findings and suggests new treatment and prevention strategies","volume":"1617","author":"Anders","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2016.05.010_bb0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000343972","article-title":"The question of pro-inflammatory immune activity in schizophrenia and the potential importance of anti-inflammatory drugs","volume":"28","author":"Arolt","year":"2013","journal-title":"Mod. Trends Pharmacopsychiatri."},{"issue":"5","key":"10.1016\/j.schres.2016.05.010_bb0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-3223(94)00299-I","article-title":"Cytokine production in drug-free and neuroleptic-treated schizophrenic patients","volume":"38","author":"Bessler","year":"1995","journal-title":"Biol. Psychiatry"},{"issue":"19","key":"10.1016\/j.schres.2016.05.010_bb0035","doi-asserted-by":"crossref","first-page":"11354","DOI":"10.1073\/pnas.95.19.11354","article-title":"Transgenic mice for interleukin 3 develop motor neuron degeneration associated with autoimmune reaction against spinal cord motor neurons","volume":"95","author":"Chavany","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.schres.2016.05.010_bb0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.mp.4001932","article-title":"Interleukin 3 and schizophrenia: the impact of sex and family history","volume":"12","author":"Chen","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2016.05.010_bb0045","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0006-3223(94)00363-8","article-title":"Impaired mitogen (PHA) responsiveness and increased autoantibodies in Caucasian schizophrenic patients with the HLA B8\/DR3 phenotype","volume":"37","author":"Chengappa","year":"1995","journal-title":"Biol. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2016.05.010_bb0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","article-title":"A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors","volume":"76","author":"de Leon","year":"2005","journal-title":"Schizophr. Res."},{"issue":"5300","key":"10.1016\/j.schres.2016.05.010_bb0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.275.5300.661","article-title":"Regulation of neuronal survival by the serine-threonine protein kinase Akt","volume":"275","author":"Dudek","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.schres.2016.05.010_bb0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1586\/14737175.7.7.789","article-title":"Inflammation and schizophrenia","volume":"7","author":"Fan","year":"2007","journal-title":"Expert. Rev. Neurother."},{"issue":"1\u20133","key":"10.1016\/j.schres.2016.05.010_bb0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.psychres.2006.07.011","article-title":"Elevated serum levels of C-reactive protein are associated with more severe psychopathology in subgroup of patients with schizophrenia","volume":"149","author":"Fan","year":"2007","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.schres.2016.05.010_bb0075","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.biopsych.2013.01.001","article-title":"Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia","volume":"73","author":"Fineberg","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2016.05.010_bb0080","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.2000.7601","article-title":"Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain","volume":"168","author":"Giralt","year":"2001","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.schres.2016.05.010_bb0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biopsych.2013.12.002","article-title":"The cytokine model of schizophrenia: emerging therapeutic strategies","volume":"75","author":"Girgis","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2016.05.010_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0166-2236(95)80029-2","article-title":"Cytokines and the nervous system. I: expression and recognition","volume":"18","author":"Hopkins","year":"1995","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2016.05.010_bb0095","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.biopsych.2013.06.010","article-title":"Immune system disturbances in schizophrenia","volume":"75","author":"Horvath","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2016.05.010_bb0100","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.pnpbp.2005.03.010","article-title":"Apoptotic mechanisms in the pathophysiology of schizophrenia","volume":"29","author":"Jarskog","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2016.05.010_bb0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0006-8993(90)91775-C","article-title":"Trophic effect of granulocyte-macrophage colony-stimulating factor on central cholinergic neurons in vitro","volume":"532","author":"Kamegai","year":"1990","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.schres.2016.05.010_bb0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S0033291712000736","article-title":"Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies","volume":"43","author":"Khandaker","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2016.05.010_bb0115","series-title":"Is there a Role for Immune-to-Brain Communication in Schizophrenia? Psychopharmacology","author":"Khandaker","year":"2015"},{"issue":"3","key":"10.1016\/j.schres.2016.05.010_bb0120","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2016.05.010_bb0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0920-9964(99)00171-1","article-title":"Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics","volume":"44","author":"Kim","year":"2000","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2016.05.010_bb0130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jnr.490410503","article-title":"Demonstration of interleukin-3 receptor-associated antigen in the central nervous system","volume":"41","author":"Konishi","year":"1995","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.schres.2016.05.010_bb0135","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","article-title":"Cytokines and the brain: implications for clinical psychiatry","volume":"157","author":"Kronfol","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.05.010_bb0140","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00087.2015","article-title":"Long-term pathological consequences of prenatal infection: beyond brain disorders","volume":"309","author":"Labouesse","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.schres.2016.05.010_bb0145","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.mp.4001983","article-title":"Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia","volume":"12","author":"Lencz","year":"2007","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2016.05.010_bb0150","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neubiorev.2004.10.012","article-title":"Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia","volume":"29","author":"Meyer","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2016.05.010_bb0155","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/schbul\/sbn022","article-title":"A review of the fetal brain cytokine imbalance hypothesis of schizophrenia","volume":"35","author":"Meyer","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2016.05.010_bb0160","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.neuropharm.2011.01.009","article-title":"To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models","volume":"62","author":"Meyer","year":"2012","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.schres.2016.05.010_bb0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2016.05.010_bb0170","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.biopsych.2012.09.007","article-title":"Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects","volume":"73","author":"Miller","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.05.010_bb0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0447.1993.tb03331.x","article-title":"T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy","volume":"87","author":"M\u00fcller","year":"1993","journal-title":"Acta Psychiatr. Scand."},{"issue":"8","key":"10.1016\/j.schres.2016.05.010_bb0180","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.2174\/138920112800784826","article-title":"Immunological treatment options for schizophrenia","volume":"13","author":"M\u00fcller","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"3","key":"10.1016\/j.schres.2016.05.010_bb0185","first-page":"292","article-title":"The role of anti-inflammatory treatment in psychiatric disorders","volume":"25","author":"M\u00fcller","year":"2013","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.schres.2016.05.010_bb0190","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fnins.2015.00372","article-title":"The role of inflammation in schizophrenia","volume":"9","author":"M\u00fcller","year":"2015","journal-title":"Front. Neurosci."},{"issue":"8","key":"10.1016\/j.schres.2016.05.010_bb0195","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2016.05.010_bb0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1750-3639.1999.tb00220.x","article-title":"Response of glia, mast cells and the blood brain barrier, in transgenic mice expressing interleukin-3 in astrocytes, an experimental model for CNS demyelination","volume":"9","author":"Powell","year":"1999","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.schres.2016.05.010_bb0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0278-5846(94)00106-R","article-title":"Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients","volume":"19","author":"Sirota","year":"1995","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2016.05.010_bb0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.9758\/cpn.2013.11.3.107","article-title":"The neuroimmunology of schizophrenia","volume":"11","author":"Smyth","year":"2013","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2016.05.010_bb0215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/YCO.0000000000000153","article-title":"Schizophrenia and psychoneuroimmunology: an integrative view","volume":"28","author":"Sperner-Unterweger","year":"2015","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.05.010_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.schres.2014.07.025","article-title":"Neuroimmune biomarkers in schizophrenia","volume":"176","author":"Tomasik","year":"2016","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2016.05.010_bb0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.schres.2016.05.010_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014422","article-title":"Plasma protein profiling reveals protein clusters related to BMI and insulin levels in middle-aged overweight subjects","volume":"5","author":"van Dijk","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.schres.2016.05.010_bb0235","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1084\/jem.188.4.635","article-title":"Interleukin 3 prevents delayed neuronal death in the hippocampal CA1 field","volume":"188","author":"Wen","year":"1998","journal-title":"J. Exp. Med."},{"issue":"1\u20132","key":"10.1016\/j.schres.2016.05.010_bb0240","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.psychres.2015.07.029","article-title":"Increased IL-3 serum levels in chronic patients with schizophrenia: associated with psychopathology","volume":"229","author":"Xiu","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2016.05.010_bb0245","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2202-8-82","article-title":"Interleukin-3 prevents neuronal death induced by amyloid peptide","volume":"8","author":"Zambrano","year":"2007","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.schres.2016.05.010_bb0250","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0920-9964(01)00296-1","article-title":"Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia association with psychopathology","volume":"57","author":"Zhang","year":"2002","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416302328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416302328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:47:03Z","timestamp":1567990023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416302328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":48,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0920996416302328"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.05.010","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}